3 months of glp 1 From pharmacy to pantry: how GLP-1 drugs are shifting consumer preferences and shopping patterns GLP-1 RA prescription trends: January

Contribution to the growing knowledge base through systematic outcome tracking and adverse event reporting would benefit the broader medical community and patients potentially benefiting from this novel therapeutic approach

Immunofluorescence tissues were mounted with ProLong Gold (Life Technologies, Cat# P36934), while H&E and immunohistochemistry tissues were mounted with Permount mounting media (Fisher Scientific, Cat# SP15500) and coverslipped for imaging

The effects of dose and duration were similar in trials for diabetes

Some people taking GLP1 medications for weight or metabolic health have reported unexpected changes in areas that overlap with ADHD, such as: Feeling calmer Experiencing fewer cravings or less food noise Noticing less impulsive eating Feeling more emotionally steady Some people with ADHD have also wondered whether these changes could relate to focus, motivation, or impulse control